Cargando…

Blood Pressure Reducing Potential and Renoprotective Action of Cilnidipine Among Hypertensive Patients Suffering From Chronic Kidney Disease: A Meta-Analysis

Hypertension is a risk factor for cardiovascular diseases which also causes progressive kidney damage leading to chronic kidney disease (CKD), so the rate of progression of CKD can be controlled by reducing blood pressure (BP). Many anti-hypertensive drugs are available. Cilnidipine is a new-generat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumari, Kusum, Sinha, Ritesh, Toppo, Mary S, Mishra, Priyanki, Alam, Shadab, Majhee, Lakhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194430/ https://www.ncbi.nlm.nih.gov/pubmed/37213948 http://dx.doi.org/10.7759/cureus.37774

Ejemplares similares

Comparative Study of the Effect of Liraglutide and Donepezil on Learning and Memory in Diazepam-Induced Amnesic Albino Rats
por: Kumari, Kusum, et al.
Publicado: (2023)

Serum Triglyceride Lowering Effect of Cilnidipine in Patients With Essential Hypertension
por: Kumar, Prakash, et al.
Publicado: (2016)

Blood pressure-lowering effect of telmisartan compared to losartan among mild to moderate essential hypertensive adult subjects: A meta-analysis
por: Kumari, Kusum, et al.
Publicado: (2022)

Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats
por: Aritomi, Shizuka, et al.
Publicado: (2015)

Renal Function in Hypertensive Patients Receiving Cilnidipine and L-Type Calcium Channel Blockers: A Meta-Analysis of Randomized Controlled and Retrospective Studies
por: Srivathsan, Mayakalyani, et al.
Publicado: (2022)

Excellent Tolerance to Cilnidipine in Hypertensives with Amlodipine - Induced Edema
por: Shetty, Ranjan, et al.
Publicado: (2013)

Effects of Cilnidipine on Heart Rate and Uric Acid Metabolism in Patients With Essential Hypertension
por: Das, Arijit, et al.
Publicado: (2016)

Preparation and evaluation of cilnidipine microemulsion
por: Tandel, Hemal, et al.
Publicado: (2012)

Cilnidipine induced ankle edema
por: Annil, Vishal R., et al.
Publicado: (2014)

Assessment of Knowledge and Awareness Among Nurses of a Tertiary Care Hospital Regarding the Management of Acute Poisoning: A Cross-Sectional Study
por: Kumari, Kusum, et al.
Publicado: (2023)

Cilnidipine lowered psychological stress-induced increase in blood pressure in a hypertensive man: a case report
por: Hayashida, Sota, et al.
Publicado: (2007)

Comparative effects of valsartan plus cilnidipine or hydrochlorothiazide on nocturnal home blood pressure
por: Fujiwara, Takeshi, et al.
Publicado: (2021)

Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats
por: Takai, Shinji, et al.
Publicado: (2013)

Comparison of effects of cilnidipine and azelnidipine on blood pressure, heart rate and albuminuria in type 2 diabetics with hypertension: A pilot study
por: Abe, Hiroko, et al.
Publicado: (2012)

Reduction of microalbuminuria in type-2 diabetes mellitus with angiotensin-converting enzyme inhibitor alone and with cilnidipine
por: Singh, V. K., et al.
Publicado: (2015)

Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: A prospective study
por: Adake, Prabhakar, et al.
Publicado: (2015)

Role of aliskiren in blood pressure control and renoprotection
por: Trimarchi, Hernán
Publicado: (2011)

Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers
por: Lee, Jieon, et al.
Publicado: (2014)

The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
por: Thomas, M. C., et al.
Publicado: (2012)

L/N-Type Calcium Channel Blocker Cilnidipine Added to Renin-Angiotensin Inhibition Improves Ambulatory Blood Pressure Profile and Suppresses Cardiac Hypertrophy in Hypertension with Chronic Kidney Disease
por: Kanaoka, Tomohiko, et al.
Publicado: (2013)

A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine
por: Dalal, Jamshed, et al.
Publicado: (2022)

Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials
por: Chakraborty, Rabindra Nath, et al.
Publicado: (2021)

Dialysis Patients With Restless Leg Syndrome: Can We Relieve Their Suffering?
por: Salib, Marina, et al.
Publicado: (2020)

Renoprotective Action of a Matrix Metalloproteinase Inhibitor in Progressive Mesangioproliferative Nephritis
por: Kuroda, Takayuki, et al.
Publicado: (2012)

Renoprotective Effect of KLF2 on Glomerular Endothelial Dysfunction in Hypertensive Nephropathy
por: Bae, Eunjin, et al.
Publicado: (2022)

Inhibition of Contractility of Isolated Caprine Detrusor by the Calcium Channel Blocker Cilnidipine and Reversal by Calcium Channel Openers
por: Maria, Steffi A., et al.
Publicado: (2023)

Does Tobacco Use Enhance the Risk of SARS-CoV-2 Infection: Evidence from Eastern Indian Population
por: Rai, Arpita, et al.
Publicado: (2023)

Renoprotective effects of garlic
por: Nasri, Hamid
Publicado: (2013)

Renoprotective effects of metformin
por: Nasri, Running Hamid
Publicado: (2013)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Ambulatory blood pressure monitoring in children suffering from orthostatic hypertension
por: Zhixiang, Yang, et al.
Publicado: (2018)

Renoprotective Effect of Human Umbilical Cord–Derived Mesenchymal Stem Cells in Immunodeficient Mice Suffering from Acute Kidney Injury
por: Fang, Te-Chao, et al.
Publicado: (2012)

Effects of Cilnidipine, an L/N-Type Calcium Channel Blocker, on Carotid Atherosclerosis in Japanese Post-Stroke Hypertensive Patients: Results from the CA-ATTEND Study
por: Nezu, Tomohisa, et al.
Publicado: (2018)

Effects of the N/L‐Type Calcium Channel Blocker Cilnidipine on Nephropathy and Uric Acid Metabolism in Hypertensive Patients With Chronic Kidney Disease (J‐CIRCLE Study)
por: Uchida, Shunya, et al.
Publicado: (2014)

Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control
por: Rashid, Haroon-Ur
Publicado: (2010)

A Prospective, Randomized Open-Label Study for Assessment of Antihypertensive Effect of Telmisartan Versus Cilnidipine Using Ambulatory Blood Pressure Monitoring (START ABPM Study)
por: Sawant, Rahul, et al.
Publicado: (2023)

Molecular Mechanisms of Hypertensive Nephropathy: Renoprotective Effect of Losartan through Hsp70
por: Costantino, Valeria Victoria, et al.
Publicado: (2021)

Modeling the renoprotective mechanisms of SGLT2 inhibition in hypertensive chronic kidney disease
por: Clemmer, John S., et al.
Publicado: (2023)

Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
por: Gopinath, Sameera, et al.
Publicado: (2019)

Cilnidipine and magnesium sulfate supplement ameliorates hyperglycemia, dyslipidemia and inhibits oxidative-stress in fructose-induced diabetic rats
por: Khatun Kali, Most. Sumaiya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_43a3af5tvalpsk9ip0dciev9b7